Clinical Trial Update: Amyloid-β Clearance Mechanisms in Alzheimer's Disease

View source ↗

Summary

This clinical trial is investigating amyloid-β clearance mechanisms in Alzheimer's disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Alzheimer's Disease (AD) | Status: RECRUITING